2021年科研论文发表情况
发布时间：2022-04-01
| 序号 | 发表论文年度月份 | 作者 | 通讯作者 | 完成单位信息 | 论文题目 |
| 1 | 2021/1 | 刘慧 | 董子钢 | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Hui Liu#, Kangdong Liu, Zigang Dong*. Targeting CDK12 for Cancer Therapy: Function, Mechanism, and Drug Discovery. Cancer Res. 2021 Jan 1;81(1):18-26. |
| 2 | 2021/1 | 杜瑞娟，黄春田 | 董子钢，李翔 | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Ruijuan Du #, Chuntian Huang #, Kangdong Liu, Xiang Li, Zigang Dong.Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy.Mol Cancer. 2021 Jan 15;20(1):15. |
| 3 | 2021/1 | 程丹 | 董子钢，李翔 | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Dan Cheng#, Jing Wang, Zigang Dong*, Xiang Li*.Cancer-related circular RNA: diverse biological functions.Cancer Cell Int. 2021 Jan 6;21(1):11. |
| 4 | 2021/1 | 顾廷轩，赵四敏 | 董子钢 | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Tingxuan Gu#, Simin Zhao#, Guoguo Jin, Mengqiu Song, Yafei Zhi, Ran Zhao, Fayang Ma, Yaqiu Zheng, Keke Wang, Hui Liu, Mingxia Xin, Wei Han , Xiang Li, Christopher D Dong, Kangdong Liu, Zigang Dong*. Front Immunol. 2021 Jan 28;11:621441. |
| 5 | 2021/3 | 刘慧 | 董子钢 | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Hui Liu, Kangdong Liu, Zigang Dong*.The Role of p21-Activated Kinases in Cancer and Beyond: Where Are We Heading? Front Cell Dev Biol. 2021 Mar 16;9:641381. |
| 6 | 2021/3 | 刘慧 | 董子钢 | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Hui Liu, Mangaladoss Fredimoses, Peijia Niu, Tingting Liu, Yan Qiao, Xueli Tian, Xiaobing Chen, Dong Joon Kim, Xiang Li, Kangdong Liu, Zigang Dong*. EPRS/GluRS promotes gastric cancer development via WNT/GSK-3β/β-catenin signaling pathway. Gastric Cancer. 2021 Mar 19. |
| 7 | 2021/5 | 马法洋，Kyle Laster，聂文娜 | 董子钢，刘康栋 | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Fayang Ma#, Kyle Laster#, Wenna Nie, Fangfang Liu, Dong Joon Kim, Mee-Hyun Lee, Ruihua Bai, Rendong Yang, Kangdong Liu*, Zigang Dong*，Heterogeneity Analysis of Esophageal Squamous Cell Carcinoma in Cell Lines, Tumor Tissues and Patient-Derived Xenografts. J Cancer. 2021 May 10;12(13):3930-3944. |
| 8 | 2021/3 | 付晓荣，赵冉 | 董子钢，Mee-Hyun Lee | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Xiaorong Fu#, Ran Zhao#, Goo Yoon, Jung-Hyun Shim, Bu Young Choi, Fanxiang Yin, Beibei Xu, Kyle Vaughn Laster, Kangdong Liu, Zigang Dong*, Mee-Hyun Lee*.3-Deoxysappanchalcone Inhibits Skin Cancer Proliferation by Regulating T-Lymphokine-Activated Killer Cell-Originated Protein Kinase in vitro and in vivo. Front Cell Dev Biol. 2021 Mar 25;9:638174. |
| 9 | 2021/6 | 胡亚美 | 董子钢，刘康栋 | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Yamei Hu#, Fangfang Liu, Xuechao Jia, Penglei Wang, Tingxuan Gu, Hui Liu, Tingting Liu, Huifang Wei, Hanyong Chen, Jiuzhou Zhao, Ran Yang, Yingying Chen, Zigang Dong*, Kangdong Liu*. Periplogenin suppresses the growth of esophageal squamous cell carcinoma in vitro and in vivo by targeting STAT3.Oncogene. 2021 Jun;40(23):3942-3958. |
| 10 | 2021/3 | 谢宵梦 | 董子钢，Dong Joon Kim | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Xiaomeng Xie, Xueyin Zu, Kyle Laster, Zigang Dong, Dong Joon Kim. 2,6-DMBQ suppresses cell proliferation and migration via inhibiting mTOR/AKT and p38 MAPK signaling pathways in NSCLC cells.J Pharmacol Sci. 2021 Mar;145(3):279-288. |
| 11 | 2021/3 | 谢宵梦 | 董子钢，Dong Joon Kim | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Xiaomeng Xie#, Xiangyu Wang, Xiaodan Shi, Yuanyuan Zhang, Kyle Vaughn Laster, Kangdong Liu, Zigang Dong*, Dong Joon Kim*. Anwulignan is a novel JAK1 inhibitor that suppresses non-small cell lung cancer growth. J Cell Mol Med. 2021 Mar;25(5):2645-2654. |
| 12 | 2021/7 | 谢祎飞 | 董子钢，刘康栋 | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Yifei Xie#, Ke Yao, Zigang Dong*, Kangdong Liu*. Targeting nutrient metabolism with FDA-approved drugs for cancer chemoprevention: Drugs and mechanisms. Cancer Lett. 2021 Jul 10;510:1-12. |
| 13 | 2021/5 | 贾雪超 | 董子钢，刘康栋 | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Xuechao Jia#, Chuntian Huang, Yamei Hu, Qiong Wu, Fangfang Liu, Wenna Nie, Hanyong Chen, Xiang Li, Zigang Dong*, Kangdong Liu*.Cirsiliol targets tyrosine kinase 2 to inhibit esophageal squamous cell carcinoma growth in vitro and in vivo. J Exp Clin Cancer Res. 2021 Mar 17;40(1):105. |
| 14 | 2021/6 | 张曼 | 董子钢，Mee-Hyun Lee | 中美（河南）荷美尔肿瘤研究院 | Man Zhang, Rui Wang, Jie Tian, Mengqiu Song, Ran Zhao, Kangdong Liu, Feng Zhu, Jung-Hyun Shim, Zigang Dong, Mee-Hyun Lee. Targeting LIMK1 with luteolin inhibits the growth of lung cancer in vitro and in vivo.J Cell Mol Med. 2021 Jun;25(12):5560-5571. |
| 15 | 2021/6 | 石晓丹 | 董子钢，Dong Joon Kim | 中美（河南）荷美尔肿瘤研究院 | Xiaodan Shi, Yuanyuan Zhang, Xiaomeng Xie, Mengjun Pang, Kyle Laster, Jian Li, Xinli Ma, Kangdong Liu, Zigang Dong, Dong Joon Kim. Ipriflavone Suppresses Growth of Esophageal Squamous Cell Carcinoma Through Inhibiting mTOR In Vitro and In Vivo.Front Oncol. 2021 Jun 10;11:648809. |
| 16 | 2021/6 | 李博，余音，江亚南 | 刘康栋，赵继敏 | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Bo Li #, Yin Yu #, Yanan Jiang #, Lili Zhao, Ang Li, Mingzhu Li, Baoyin Yuan, Jing Lu, Ziming Dong, Jimin Zhao, Kangdong Liu.Cloperastine inhibits esophageal squamous cell carcinoma proliferation in vivo and in vitro by suppressing mitochondrial oxidative phosphorylation.Cell Death Discov. 2021 Jun 21;7(1):166. |
| 17 | 2021/5 | 王园园，顾廷轩 | Mee-Hyun Lee | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Yuanyuan Wang#, Tingxuan Gu# , Xueli Tian, Wenwen Li , Ran Zhao, Wenqian Yang, Quanli Gao, Tiepeng Li, Jung-Hyun Shim, Chengjuan Zhang, Kangdong Liu, Mee-Hyun Lee.A Small Molecule Antagonist of PD-1/PD-L1 Interactions Acts as an Immune Checkpoint Inhibitor for NSCLC and Melanoma Immunotherapy. Front Immunol. 2021 May 14;12:654463. |
| 18 | 2021/8 | 武想雨,王梓童，江亚南 | 董子钢，刘康栋 | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Xiangyu Wu, Zitong Wang, Yanan Jiang, Hao Zhou, Ang Li, Yaxing Wei, Zhuo Bao, Donghao Wang, Jimin Zhao, Xinhuan Chen, Yaping Guo, Zigang Dong and Kangdong Liu, Tegaserod Maleate Inhibits Esophageal Squamous Cell Carcinoma Proliferation by Suppressing the Peroxisome Pathway. Front. Oncol., 04 August 2021 |
| 19 | 2021/11 | 刘慧 | 董子钢 | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Hui Liu, Zigang Dong. Cancer Etiology and Prevention Principle: "1 + X". Cancer Res . 2021 Nov 1;81(21):5377-5395. |
| 20 | 2021/10 | 刘方方，吴琼 | 董子钢，刘康栋 | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Fangfang Liu, Qiong Wu, Wei Han, Kyle Laster, Yamei Hu, Fayang Ma, Hanyong Chen, Xueli Tian, Yan Qiao, Hui Liu, Dong Joon Kim, Zigang Dong, Kangdong Liu. Targeting integrin αvβ3 with indomethacin inhibits patient-derived xenograft tumour growth and recurrence in oesophageal squamous cell carcinoma. Clin Transl Med. 2021Oct; 11(10): e548. |
| 21 | 2021/12 | 韦亚星，吴文杰，江亚南 | 赵继敏，刘康栋 | 郑州大学基础医学院，中美（河南）荷美尔肿瘤研究院 | Yaxing Wei #, Wenjie Wu #, Yanan Jiang #, Hao Zhou, Yin Yu, Lili Zhao, Xiangyu Wu, Xuebo Lu, Qiang Yuan, Zitong Wang, Zigang Dong, Luyun He, Jimin Zhao, Kangdong Liu. Nuplazid suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting PAK4. Br J Cancer. 2021 Dec 15 |
上一篇： 2022年科研论文发表情况
下一篇： 2020年科研论文发表情况
